These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3340263)

  • 1. Lack of relationship between urinary glycosaminoglycans and indices of tubular or glomerular renal damage. Urinary GAG are an unreliable nephrotoxicity index.
    Bernard AM; Ouled A; Roels H; Lauwerys R; Vandeleene B; Lambert A
    Nephron; 1988; 48(1):82-3. PubMed ID: 3340263
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.
    Roels HA; Hoet P; Lison D
    Ren Fail; 1999; 21(3-4):251-62. PubMed ID: 10416202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alcohol on urinary glycosaminoglycan and protein excretion in normal and diabetic mice.
    Ramamurthi R; Leevy CB; Reddi AS
    Alcohol Alcohol; 1990; 25(1):45-50. PubMed ID: 2334495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic microangiopathy and urinary glycosaminoglycans.
    Kahaly G; Hansen C; Otto E; Förster G; Beyer J; Hommel G
    Exp Clin Endocrinol Diabetes; 1997; 105(3):145-51. PubMed ID: 9228510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of [35S]sulfate into glomerular membranes of rats chronically exposed to cadmium and its relation with urinary glycosaminoglycans and proteinuria.
    Cárdenas A; Bernard A; Lauwerys R
    Toxicology; 1992 Dec; 76(3):219-31. PubMed ID: 1471159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein excretion patterns in cadmium-exposed individuals: high resolution electrophoresis.
    Falck FY; Keren DF; Fine LJ; Smith RG; McClatchey KD; England B; Annesley T
    Arch Environ Health; 1984; 39(2):69-73. PubMed ID: 6721587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment of nephrotoxicity of cadmium.
    Fels LM
    Ren Fail; 1999; 21(3-4):275-81. PubMed ID: 10416204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
    McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR
    Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
    Tencer J; Torffvit O; Björnsson S; Thysell H; Grubb A; Rippe B
    Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cadmium overload without nephrotoxicity.
    Ghose RR; Morgan WD; Cummins PE
    Br J Ind Med; 1981 May; 38(2):185-6. PubMed ID: 7236544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of glycosaminoglycans in urological disease.
    Baggio B; Gambaro G; Cicerello E; Mastrosimone S; Marzaro G; Borsatti A; Pagano F
    Clin Biochem; 1987 Dec; 20(6):449-50. PubMed ID: 3436040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal fibronectin excretion as a marker for renal environmental toxins.
    Bundschuh I; Herbort C; Fels LM; Jung K; Graubaum HJ; Stolte H
    Contrib Nephrol; 1993; 101():177-84. PubMed ID: 8467673
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycosaminoglycans in urine of type 1 diabetic patients.
    Sindelka G; Skrha J; Stibor V; Stolba P
    Sb Lek; 1993; 94(1):77-80. PubMed ID: 7992002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
    Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies.
    Morales E; Valero MA; León M; Hernández E; Praga M
    Am J Kidney Dis; 2003 Feb; 41(2):319-27. PubMed ID: 12552492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microdetermination of urinary protein for the prevention of occupational renal disorders (author's transl)].
    Onodera M; Sakurai H
    Sangyo Igaku; 1976 Nov; 18(6):511-5. PubMed ID: 1036189
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.
    Liou HH; Huang TP; Campese VM
    Nephron; 1995; 69(1):41-8. PubMed ID: 7891796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
    De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
    J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of glycosaminoglycans in patients with early diabetic nephropathy.
    Pérez-Blanco F; Moreno-Terribas G; Cantero-Hinojasa J; Rodríguez-Cuartero A
    Nephron; 1996; 73(2):344-5. PubMed ID: 8773381
    [No Abstract]   [Full Text] [Related]  

  • 20. Size and charge selectivity of the glomerular filter in patients with insulin-dependent diabetes mellitus: urinary immunoglobulins and glycosaminoglycans.
    Torffvit O; Rippe B
    Nephron; 1999; 83(4):301-7. PubMed ID: 10575291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.